Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F
Gaggar, Anuj
Lau, Audrey
Liu, Yang
Wu, George
Suri, Vithika
Tan, Susanna K
Subramanian, G Mani
Trinh, Huy
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L Y
Funding for this research was provided by:
Gilead Sciences
Gilead Sciences
This article is maintained by: Elsevier
Article Title: Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Journal Title: The Lancet Gastroenterology & Hepatology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2468-1253(19)30421-2
CrossRef DOI link to the associated document: https://doi.org/10.1016/S2468-1253(19)30450-9
Content Type: article
Copyright: © 2020 Elsevier Ltd. All rights reserved.